Priya Abraham - Concepedia

Author

Priya Abraham

ICMR-National Institute of Virology ORCID

Also Known As

Abraham, P., Abraham, Priya, Atanu Basu, Dr. Priya Abraham, K M Krishnamoorthy, Neeraj Aggarwal, Nivedita Gupta, P Abraham, P. ABRAHAM, P. Abraham

314

Publications

9.6K

Citations

H-Index

137

Concepts

All Affiliations

ICMR-National Institute of Virology Christian Medical College, Vellore Indian Council of Medical Research Christian Medical College Bharat Biotech (India)

About

Priya Abraham is an author at ICMR-National Institute of Virology specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	67	4.2K
2	Business	1	1	26
3	Education	1	1	26
4	Health Sciences	1	1	22
5	Management	1	1	26

Priya Abraham

125

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, Nature	2021	1.4K
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India Sarah Cherian, Varsha Potdar, Santosh Jadhav, Microorganisms Virus EpidemiologyGeneticsCovid-19 EpidemiologyViral Structural ProteinCovid-19	2021	652
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentImmunologyVirology	2021	433
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial Raches Ella, Siddharth Reddy, Harsh Jogdand, The Lancet Infectious Diseases	2021	360
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial Raches Ella, Siddarth Reddy, William C. Blackwelder, The Lancet VaccinationVaccine SafetyVaccine DevelopmentImmunologyInterim Results	2021	358
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India Mahesh Shanker Dhar, Robin Marwal, Radhakrishnan VS, Science Sars-cov-2 VariantVirus EpidemiologyImmunodeficienciesGenetic EpidemiologyEpidemiological Dynamic	2021	311
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India Sarah Cherian, Varsha Potdar, Santosh Jadhav, Virus EpidemiologyViral PathogenesisViral Structural ProteinCovid-19Pathogen Discovery	2021	266
Full-genome sequences of the first two SARS-CoV-2 viruses from India Pragya D. Yadav, Varsha Potdar, Manohar Lal Choudhary, The Indian Journal of Medical Research	2020	173
Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease Jeyamani Ramachandran, CE Eapen, Gagandeep Kang, Journal of Gastroenterology and Hepatology	2004	144
Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees Pragya D. Yadav, Gajanan Sapkal, Priya Abraham, Investigation B.1.617Viral DiagnosticsImmunologyCovid-19Emerging Infectious Disease	2021	137

Page 1